← Open Payments lookup

PARIS MANDY: Open Payments

NPI 1205502283 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,207 in 130 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $359 · 2025 $3,207

Food & beverage: $3,207
CompanyPaymentsAmount
ABBVIE INC.40$845
Alkermes, Inc.13$370
E.R. Squibb & Sons, L.L.C.9$366
Vanda Pharmaceuticals Inc.11$313
Corium, LLC12$311
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$179
Neurocrine BioSciences, Inc.6$157
Teva Pharmaceuticals USA, Inc.9$136
Janssen Pharmaceuticals, Inc6$132
Axsome Therapeutics, Inc.6$127

Products named: VRAYLAR, COBENFY, FANAPT, Azstarys, ARISTADA, LYBALVI, CAPLYTA, INGREZZA.

Industry payments across AZ — which companies pay providers there.